Priya Sriskandarajah

7PUBLICATIONS
29CO-AUTHORS
Molecular targetsRespiratory diseasesHaematological tumoursMedical biotechnology diagnostics (incl. biosensors)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 08, 2026
Roginolisib in Combination with JAK Inhibitors in Patients with Myelofibrosis Who are Unresponsive to Approved JAK Inhibitors (Study HEMA-MED) - A Trial in Progress.

|Jul 24, 2026
Anemia of Chronic Disease: Pathophysiology, Diagnosis and Management.

|Jul 13, 2026
Pure red cell aplasia in a patient with rheumatoid arthritis after JAK inhibitor exposure-diagnostic challenges.

|Jun 12, 2026
Prognostic Scores and Risk Stratification of Myeloproliferative Neoplasms: 2026 Updates.

|Mar 26, 2026
Prefibrotic myelofibrosis: recent updates in diagnosis, prognostication, and management 2026.

Noor Al-Zubaidi, Katherine Makris, Priya Sriskandarajah

|Mar 14, 2026
The Management of Menopause in Women with Philadelphia-Negative Myeloproliferative Neoplasms: Clinical Challenges and Therapeutic Considerations.

Claire Woodley, Priya Sriskandarajah

Pageof 2

Frequent Collaborators

1 joint publications

Andrea Duminuco

1 joint publications

Hugues de Lavallade

1 joint publications

Shahram Kordasti

1 joint publications

Giuseppe A Palumbo